Le Lézard
Classified in: Health
Subjects: NPT, LEG, LGB, AVO

HHS Corrects Dangerous Obamacare rule, says Family Research Council


WASHINGTON, June 12, 2020 /PRNewswire/ -- The Department of Health and Human Services finalized a rule today that revises 2016 provisions of the Obamacare section 1557 rule that had redefined discrimination "on the basis of sex" to include "gender identity" and "pregnancy termination."

Mary Beth Waddell, who serves as the Senior Legislative Assistant for Family Research Council, released the following statement:

"The Department of Health and Human Services has corrected a dangerous Obamacare rule that distorted key portions of the legislation to the detriment of both medical professionals and patients.

"Under the old Obama rule, medical professionals could have been forced to facilitate gender reassignment surgeries and abortions ? even if they believed this was a violation of their conscience or believed it harmful to the patient. Fortunately, soon after it was finalized, the courts blocked the far-reaching rule that was clearly unconstitutional.      

"Gender transition procedures are not fully embraced within the medical community because of their severe negative, psychological, and physical impacts. These negative impacts have only become more apparent in the last four years since the Obama rule was adopted.  The Obama rule failed to recognize the many unintended consequences to patients ? particularly those identifying as transgender.  For example, men and women often get different doses of medications and even different ones altogether. Men and women sometimes exhibit different symptoms for the same disease. Treating a person differently based on their self-professed gender and not their biological make-up can be not only harmful, but deadly.

"The rule finalized today helps protect health care providers from being forced to participate in and perform services that substantially violate their consciences and help protect their patients.  Family Research Council fully supports these revisions to ensure Obamacare isn't used as a vehicle to advance transgender or abortion politics," concluded Waddell.

SOURCE Family Research Council


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: